Zeenamet 2mg 500mg tabs

Overview

Zeenamet 2mg/500mg tablets are an oral antidiabetic medicine containing glimepiride 2mg and metformin hydrochloride 500mg. This fixed-dose combination is used for clinician-directed management of type 2 diabetes mellitus, especially when blood glucose control requires more than lifestyle measures alone or when a prescriber considers combined oral therapy appropriate. It should be used together with a diabetes care plan that may include balanced meals, regular physical activity, weight management, self-monitoring of blood glucose, HbA1c checks, and periodic medical review.

Glimepiride is a sulfonylurea that helps the pancreas release insulin. Metformin is a biguanide that mainly reduces glucose production by the liver and improves the body’s response to insulin. Because the medicine can lower blood sugar, the dose and timing should be individualized by a qualified healthcare professional.

Benefits

• Helps improve blood glucose control in type 2 diabetes when used with diet and exercise
• Combines two established oral antidiabetic mechanisms in one tablet
• May support fasting and post-meal glucose management under medical supervision

Key Features

• Glimepiride 2mg plus metformin HCl 500mg combination
• Oral tablet dosage form
• Used for type 2 diabetes mellitus when prescribed
• Dual antidiabetic action targeting insulin release and hepatic glucose production
• Common 30-tablet pack presentation

Dosage and How to Use

• How to use: Swallow the tablet with water. Take it consistently as directed and do not crush, split, or chew unless advised by a healthcare professional.
• Administration: Oral administration with water.
• Recommended dose: Use exactly as prescribed by a healthcare professional; the dose is individualized according to blood glucose control, prior therapy, tolerability, age, meal pattern, and kidney function.
• Adult dose: Individualized; follow the dose and schedule prescribed by the treating clinician.
• Elderly use: Use with caution in older adults because of higher risk of hypoglycemia and kidney function concerns; monitoring may be required.
• When to take: Commonly taken with meals when prescribed to reduce gastrointestinal upset and lower hypoglycemia risk; follow the prescriber’s timing instructions.
• With food: Usually taken with food when prescribed; do not skip meals while using a glimepiride-containing medicine.
• Missed dose: Take the missed dose when remembered if it is not close to the next scheduled dose. Do not double the dose; follow the prescriber’s advice.
• Overdose: Overdose may cause severe hypoglycemia and other serious effects. Seek urgent medical help or contact a poison control or healthcare service immediately.

Specifications

Side Effects

Common side effects

• Nausea
• Diarrhea
• Abdominal discomfort
• Vomiting
• Metallic taste
• Headache
• Dizziness
• Low blood sugar symptoms such as sweating, tremor, hunger, palpitations, blurred vision, or confusion

Serious side effects (seek medical help)

• Severe hypoglycemia
• Seizures or loss of consciousness due to low blood sugar
• Severe allergic reaction
• Lactic acidosis symptoms such as unusual weakness, rapid breathing, severe drowsiness, muscle pain, or abdominal distress

Allergic reaction

Seek urgent care for rash, swelling of face, lips, tongue, or throat, severe itching, wheezing, or breathing difficulty after taking the medicine.

Safety and Precautions

• Risk of hypoglycemia, especially with missed meals, alcohol, excessive exercise, or use with other antidiabetic medicines
• Metformin-containing medicines require caution in kidney impairment and conditions that increase lactic acidosis risk
• Not for type 1 diabetes or diabetic ketoacidosis
• Monitor blood glucose regularly as advised
• Inform the doctor about kidney, liver, heart, or severe infection history
• Tell healthcare professionals before surgery or iodinated contrast imaging
• Maintain regular meals and avoid unsafe alcohol use

When not to use

Do not use in patients with known hypersensitivity to glimepiride, metformin, sulfonylureas, or related components. Avoid use in diabetic ketoacidosis and severe renal impairment unless a clinician specifically determines suitability.

Special populations

• Pregnancy: Use during pregnancy only if a healthcare professional determines it is appropriate; diabetes treatment often requires close monitoring during pregnancy.
• Breastfeeding: Consult a healthcare professional before use while breastfeeding because medicine choice and infant monitoring may need review.
• Liver: Use with caution or avoid in significant liver disease unless specifically advised by a clinician; liver impairment may increase safety risks.
• Kidney: Kidney function assessment is important with metformin-containing medicines. Avoid use in severe renal impairment unless specifically directed by a qualified clinician.
• Heart: Inform the doctor about heart failure, recent heart attack, or circulatory problems before use because these conditions may influence metformin safety.
• Driving: Low blood sugar can impair concentration and reaction time. Avoid driving or operating machinery if symptoms of hypoglycemia or dizziness occur.
• Alcohol: Avoid excessive alcohol. Alcohol may increase the risk of hypoglycemia and metformin-associated adverse effects, including lactic acidosis risk.

Interactions

Drugs:

• Insulin or other antidiabetic medicines may increase hypoglycemia risk
• Beta-blockers may mask warning signs of low blood sugar
• Corticosteroids and some diuretics may raise blood glucose
• Some antibiotics, antifungals, NSAIDs, ACE inhibitors, and medicines affecting kidney function may alter safety or glucose control
• Iodinated contrast procedures may require temporary metformin management under medical advice

Food:

• Skipping meals, prolonged fasting, or irregular carbohydrate intake may increase hypoglycemia risk. Alcohol should be avoided or limited as advised by a clinician.

Conditions:

• Renal impairment
• Liver disease
• Heart failure or recent cardiovascular events
• Diabetic ketoacidosis
• Severe infection, dehydration, or major surgery
• History of severe hypoglycemia

Storage and Disposal

• Store in the original packaging away from heat, moisture, and direct sunlight.
• Store at room temperature unless the product pack or pharmacist advises otherwise.
• Keep out of reach and sight of children.
• Dispose of expired or unused tablets through a pharmacy take-back option or according to local disposal guidance; do not leave loose tablets accessible.

Disclaimer

Information is for educational and product-content purposes only and does not replace professional medical advice. Use only as directed by a qualified healthcare professional.